EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Carvacrol ameliorates doxorubicin-induced human cardiomyocyte apoptosis, inflammation and ferroptosis by inhibiting histone deacetylase 6

Jie Li, Zhenhua Wu, Nan Jiang

Letters in Drug Design & Discovery · 2026-09 · 23 (9) · 100552

DOI: 10.1016/j.lddd.2026.100552 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Letters in Drug Design & Discovery, 2026-09. Verfasst von Jie Li und 2 weiteren Autor:innen. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Li, J., Wu, Z., & Jiang, N. (2026). Carvacrol ameliorates doxorubicin-induced human cardiomyocyte apoptosis, inflammation and ferroptosis by inhibiting histone deacetylase 6. Letters in Drug Design & Discovery, 23(9), 100552. https://doi.org/10.1016/j.lddd.2026.100552

Vancouver

Li J, Wu Z, Jiang N. Carvacrol ameliorates doxorubicin-induced human cardiomyocyte apoptosis, inflammation and ferroptosis by inhibiting histone deacetylase 6. Letters in Drug Design & Discovery. 2026;23(9):100552. doi:10.1016/j.lddd.2026.100552

BibTeX
@article{Li2026,
  author = {Li, Jie and Wu, Zhenhua and Jiang, Nan},
  title = {Carvacrol ameliorates doxorubicin-induced human cardiomyocyte apoptosis, inflammation and ferroptosis by inhibiting histone deacetylase 6},
  journal = {Letters in Drug Design & Discovery},
  year = {2026},
  volume = {23},
  number = {9},
  pages = {100552},
  doi = {10.1016/j.lddd.2026.100552}
}
Kostenlos starten →